{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:20:09Z","timestamp":1731043209474,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,7]]},"DOI":"10.7759\/cureus.73190","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:04:39Z","timestamp":1730973879000},"source":"Crossref","is-referenced-by-count":0,"title":["Double-Hit Diffuse Large B-Cell Lymphoma in AIDS"],"prefix":"10.7759","author":[{"given":"Subha Sree","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swathy","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005469","article-title":"Hematologic cancers in individuals infected by HIV","volume":"139","author":"Carbone A","year":"2022","unstructured":"Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood. 2022, 139:995-1012. 10.1182\/blood.2020005469","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.396","article-title":"Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007","volume":"305","author":"Shiels MS","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Hall HI, et al.. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA. 2011, 305:1450-9. 10.1001\/jama.2011.396","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \"The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms\" Leukemia. 2022 Jul;36(7):1720-1748","volume":"37","author":"Alaggio R","year":"2023","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. Correction: \"The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms\" Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 2023, 37:1944-51. 10.1038\/s41375-023-01962-5","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani SM","year":"2020","unstructured":"Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, Gopal S. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020, 7:e641-51. 10.1016\/S2352-3018(20)30118-1","journal-title":"Lancet HIV"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123191","article-title":"Diffuse large B-cell lymphoma in the HIV setting","volume":"15","author":"Huguet M","year":"2023","unstructured":"Huguet M, Navarro JT, Molt\u00f3 J, Ribera JM, Tapia G. Diffuse large B-cell lymphoma in the HIV setting. Cancers (Basel). 2023, 15:3191. 10.3390\/cancers15123191","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13998","article-title":"Central nervous system involvement in AIDS-related lymphomas","volume":"173","author":"Barta SK","year":"2016","unstructured":"Barta SK, Joshi J, Mounier N, et al.. Central nervous system involvement in AIDS-related lymphomas. Br J Haematol. 2016, 173:857-66. 10.1111\/bjh.13998","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09046.x","article-title":"Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP","volume":"157","author":"Ribera JM","year":"2012","unstructured":"Ribera JM, Morgades M, Gonz\u00e1lez-Barca E, et al.. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP. Br J Haematol. 2012, 157:637-9. 10.1111\/j.1365-2141.2012.09046.x","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26723","article-title":"Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma","volume":"15","author":"Barta SK","year":"2012","unstructured":"Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer. 2012, 15:3977-83. 10.1002\/cncr.26723","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher RI","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, et al.. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993, 328:1002-6. 10.1056\/NEJM199304083281404","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials","volume":"1","author":"Spina M","year":"2005","unstructured":"Spina M, Jaeger U, Sparano JA, et al.. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood. 2005, 1:1891-7. 10.1182\/blood-2004-08-3300","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq068","article-title":"Tuberculosis and malignancy","volume":"103","author":"Falagas ME","year":"2010","unstructured":"Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM. 2010, 103:461-87. 10.1093\/qjmed\/hcq068","journal-title":"QJM"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_164_16","article-title":"Extrapulmonary tuberculosis of lymph node coexist with diffuse large B-cell lymphoma: a case report","volume":"38","author":"Dash SB","year":"2017","unstructured":"Dash SB, Das U, Rout N, Panda S. Extrapulmonary tuberculosis of lymph node coexist with diffuse large B-cell lymphoma: a case report. Indian J Med Paediatr Oncol. 2017, 38:391-3. 10.4103\/ijmpo.ijmpo_164_16","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study","volume":"5","author":"Fitzmaurice C","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, et al.. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2019, 5:1749-68. 10.1001\/jamaoncol.2019.2996","journal-title":"JAMA Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/904367","article-title":"AIDS-related non-Hodgkin's lymphoma in sub-Saharan Africa: current status and realities of therapeutic approach","volume":"2012","author":"Mwamba PM","year":"2012","unstructured":"Mwamba PM, Mwanda WO, Busakhala N, Strother RM, Loehrer PJ, Remick SC. AIDS-related non-Hodgkin's lymphoma in sub-Saharan Africa: current status and realities of therapeutic approach. Lymphoma. 2012, 2012:10.1155\/2012\/904367","journal-title":"Lymphoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone A","year":"2009","unstructured":"Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009, 113:1213-24. 10.1182\/blood-2008-09-180315","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-599951","article-title":"The tumor virus landscape of AIDS-related lymphomas","volume":"125","author":"Arvey A","year":"2015","unstructured":"Arvey A, Ojesina AI, Pedamallu CS, et al.. The tumor virus landscape of AIDS-related lymphomas. Blood. 2015, 125:e14-22. 10.1182\/blood-2014-11-599951","journal-title":"Blood"},{"key":"ref17","article-title":"Harrison's Principles of Internal Medicine, 21e","year":"2022","unstructured":"Harrison's Principles of Internal Medicine, 21e. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J (ed). McGraw-Hill Education, 2022."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12136","article-title":"British HIV Association guidelines for HIV-associated malignancies 2014","volume":"15 Suppl 2","author":"Bower M","year":"2014","unstructured":"Bower M, Palfreeman A, Alfa-Wali M, et al.. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014, 15 Suppl 2:1-92. 10.1111\/hiv.12136","journal-title":"HIV Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02656.x","article-title":"Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone","volume":"112","author":"Navarro JT","year":"2001","unstructured":"Navarro JT, Ribera JM, Oriol A, et al.. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol. 2001, 112:909-15. 10.1046\/j.1365-2141.2001.02656.x","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma","volume":"17","author":"Hoffmann C","year":"2003","unstructured":"Hoffmann C, Wolf E, F\u00e4tkenheuer G, et al.. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS. 2003, 17:1521-9. 10.1097\/00002030-200307040-00013","journal-title":"AIDS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/310742-double-hit-diffuse-large-b-cell-lymphoma-in-aids","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:04:40Z","timestamp":1730973880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/310742-double-hit-diffuse-large-b-cell-lymphoma-in-aids"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.73190","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,7]]}}}